申请人:Glaxo Group Limited
公开号:US20150232423A1
公开(公告)日:2015-08-20
The present invention relates to a process for the preparation of umeclidinium bromide, and to processes for preparing intermediates used in the preparation of umeclidinium bromide.
本发明涉及一种制备
溴化乌美克林的方法,以及用于制备
溴化乌美克林的中间体的制备方法。